Table 2.
Linear mixed model estimates of within- and between-arm changes in loge plasma NfL (observed data analysis).
| Estimate [95 % CI] |
|||||
|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | Model 4 | ||
| Within-arm estimated change | |||||
| HSMP | V2 – V1 | −0.07 [−0.14 to 0.00] | −0.07 [−0.14 to 0.00] | −0.07 [−0.14 to 0.00] | −0.06 [−0.14 to 0.01] |
| V3 – V1 | −0.11 [−0.18 to −0.04] | −0.11 [−0.18 to −0.04] | −0.10 [−0.18 to −0.03] | −0.10 [−0.18 to −0.02] | |
| CMBAS | V2 – V1 | −0.04 [−0.11 to 0.02] | −0.04 [−0.11 to 0.02] | −0.05 [−0.11 to 0.02] | −0.05 [−0.12 to 0.02] |
| V3 – V1 | −0.02 [−0.09 to 0.04] | −0.02 [−0.09 to 0.04] | −0.03 [−0.10 to 0.04] | −0.03 [−0.10 to 0.04] | |
| Between-arm estimated change | |||||
| HSMP – CMBAS | V2 – V1 | −0.02 [−0.12 to 0.07] p = 0.64 |
−0.02 [−0.12 to 0.07] p = 0.63 |
−0.02 [−0.12 to 0.08] p = 0.65 |
−0.02 [−0.12 to 0.09] p = 0.77 |
| V3 – V1 | −0.08 [−0.18 to 0.02] p = 0.11 |
−0.08 [−0.18 to 0.02] p = 0.10 |
−0.08 [−0.18 to 0.02] p = 0.13 |
−0.07 [−0.17 to 0.04] p = 0.21 |
|
| Data included in models | |||||
| Participants | 137 | 137 | 132* | 124† | |
| Observations | 370 | 370 | 360 | 336 | |
The unadjusted model (Model 1) included random participant intercepts (all other covariates were fixed effects), as well as trial site, visit, trial arm, and the visit × arm interaction. Model 2 adjusted Model 1 for age at baseline, sex, and education level. Model 3 adjusted Model 2 for renal insufficiency, as well as baseline BMI and PASE. Model 4 adjusted Model 3 for APOE. Continuous covariates were mean-centered. CI = confidence interval. CMBAS = caring mindfulness-based approach for seniors. HSMP = health self-management program. NfL = neurofilament light. PASE = physical activity scale for the elderly. V1 = baseline visit. V2 = post-intervention visit. V3 = follow-up visit. APOE = apolipoprotein E gene. P-tau-181 = tau phosphorylated at threonine 181.
Model 3 included 5 fewer participants versus Models 1–2 due to missingness in the PASE covariate.
Model 4 included 8 fewer participants versus Model 3 due to missingness in the APOE (n = 6) and P-tau-181 (n = 2) covariates.